Related references
Note: Only part of the references are listed.Obesity Affects HDL Metabolism, Composition and Subclass Distribution
Julia T. Stadler et al.
BIOMEDICINES (2021)
MicroRNA-144 Silencing Protects Against Atherosclerosis in Male, but Not Female Mice
Joan Cheng et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2020)
Metabolically Healthy Obesity
Matthias Blueher
ENDOCRINE REVIEWS (2020)
The role of macrophages in obesity-associated islet inflammation and β-cell abnormalities
Wei Ying et al.
NATURE REVIEWS ENDOCRINOLOGY (2020)
Current Understanding of the Relationship of HDL Composition, Structure and Function to Their Cardioprotective Properties in Chronic Kidney Disease
Gunther Marsche et al.
BIOMOLECULES (2020)
Metabolically healthy obesity: facts and fantasies
Gordon Smith et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Atherosclerosis
Peter Libby et al.
NATURE REVIEWS DISEASE PRIMERS (2019)
Anti-Inflammatory Effects of HDL (High-Density Lipoprotein) in Macrophages Predominate Over Proinflammatory Effects in Atherosclerotic Plaques
Panagiotis Fotakis et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2019)
Elevated level of lecithin: cholesterol acyltransferase (LCAT) is associated with reduced coronary atheroma burden
Catherine Gebhard et al.
ATHEROSCLEROSIS (2018)
Actions of metformin and statins on lipid and glucose metabolism and possible benefit of combination therapy
Mariel F. van Stee et al.
CARDIOVASCULAR DIABETOLOGY (2018)
HDL in CKD-The Devil Is in the Detail
Florian Kronenberg
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
Inflammation in metabolically healthy and metabolically abnormal adolescents: The HELENA study
E. M. Gonzalez-Gil et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2018)
Pharmacological Intervention to Modulate HDL: What Do We Target?
Nicholas J. Woudberg et al.
FRONTIERS IN PHARMACOLOGY (2018)
Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90 257 women (the Nurses' Health Study): 30 year follow-up from a prospective cohort study
Nathalie Eckel et al.
LANCET DIABETES & ENDOCRINOLOGY (2018)
Metabolically healthy obesity: the low-hanging fruit in obesity treatment?
Norbert Stefan et al.
LANCET DIABETES & ENDOCRINOLOGY (2018)
Atherosclerosis A Chronic Inflammatory Disease With an Autoimmune Component
Kouji Kobiyama et al.
CIRCULATION RESEARCH (2018)
Obesity
Pedro Gonzalez-Muniesa et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Causes, Characteristics, and Consequences of Metabolically Unhealthy Normal Weight in Humans
Norbert Stefan et al.
CELL METABOLISM (2017)
Cholesterol Accumulation in Dendritic Cells Links the Inflammasome to Acquired Immunity
Marit Westerterp et al.
CELL METABOLISM (2017)
Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional study
Bogdan Ene-Iordache et al.
LANCET GLOBAL HEALTH (2016)
Walk-Run Training Improves the Anti-Inflammation Properties of High-Density Lipoprotein in Patients With Metabolic Syndrome
Hui Sang et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
High-Density Lipoprotein Attenuates Th1 and Th17 Autoimmune Responses by Modulating Dendritic Cell Maturation and Function
Ioanna Tiniakou et al.
JOURNAL OF IMMUNOLOGY (2015)
The Natural Course of Healthy Obesity Over 20 Years
Joshua A. Bell et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Serum paraoxonase-1 activity is more closely related to HDL particle concentration and large HDL particles than to HDL cholesterol in Type 2 diabetic and non-diabetic subjects
Robin P. F. Dullaart et al.
CLINICAL BIOCHEMISTRY (2014)
Elevated high-density lipoprotein cholesterol and cardiovascular mortality in maintenance hemodialysis patients
Hamid Moradi et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2014)
Assessing the functional properties of high-density lipoproteins: an emerging concept in cardiovascular research
Michela Triolo et al.
BIOMARKERS IN MEDICINE (2013)
Recombinant HDLMilano exerts greater anti-inflammatory and plaque stabilizing properties than HDLwild-type
Borja Ibanez et al.
ATHEROSCLEROSIS (2012)
ABCA1 gene promoter DNA methylation is associated with HDL particle profile and coronary artery disease in familial hypercholesterolemia
Simon-Pierre Guay et al.
EPIGENETICS (2012)
Psoriasis alters HDL composition and cholesterol efflux capacity
Michael Holzer et al.
JOURNAL OF LIPID RESEARCH (2012)
Apolipoprotein A-I Attenuates Palmitate-Mediated NF-κB Activation by Reducing Toll-Like Receptor-4 Recruitment into Lipid Rafts
Andrew M. Cheng et al.
PLOS ONE (2012)
HDL Measures, Particle Heterogeneity, Proposed Nomenclature, and Relation to Atherosclerotic Cardiovascular Events
Robert S. Rosenson et al.
CLINICAL CHEMISTRY (2011)
The role of metformin and thiazolidinediones in the regulation of hepatic glucose metabolism and its clinical impact
Esther Phielix et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2011)
Seven Direct Methods for Measuring HDL and LDL Cholesterol Compared with Ultracentrifugation Reference Measurement Procedures
W. Greg Miller et al.
CLINICAL CHEMISTRY (2010)
HDL, ABC transporters, and cholesterol efflux: Implications for the treatment of atherosclerosis
Alan R. Tall et al.
CELL METABOLISM (2008)
PROCAM Study: risk prediction for myocardial infarction using microfluidic high-density lipoprotein (HDL) sub-fractionation is independent of HDL cholesterol
Odilo Mueller et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2008)
Altered lipoprotein metabolism in chronic inflammatory states: proinflammatory high-density lipoprotein and accelerated atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis
Bevra H. Hahn et al.
ARTHRITIS RESEARCH & THERAPY (2008)
High-density lipoprotein as a therapeutic target - A systematic review
Inder M. Singh et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Long-term treatment with the apoliprotein A1 mimetic peptide increases antioxidants and vascular repair in type I diabetic rats
Stephen J. Peterson et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Effect of a short-term diet and exercise intervention on inflammatory/antiinflammatory properties of HDL in overweight/obese men with cardiovascular risk factors
Christian K. Roberts et al.
JOURNAL OF APPLIED PHYSIOLOGY (2006)
ATP-binding cassette transporter A1 expression disrupts raft membrane microdomains through its ATPase-related functions
Yves D. Landry et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Consumption of saturated fat impairs the anti-inflammatory properties of high-density lipoproteins and endothelial function
Stephen J. Nicholls et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Association of paraoxonase-1 activity and concentration with angiographic severity and extent of coronary artery disease
M Granér et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects
Timothy E. Graham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Diagnosis and management of the metabolic syndrome - An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement
SM Grundy et al.
CIRCULATION (2005)
Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes
Q Yang et al.
NATURE (2005)
New insights into the regulation of HDL metabolism and reverse cholesterol transport
GF Lewis et al.
CIRCULATION RESEARCH (2005)
Reconstituted high-density lipoproteins inhibit the acute pro-oxidant and proinflammatory vascular changes induced by a periarterial collar in normocholesterolemic rabbits
SJ Nicholls et al.
CIRCULATION (2005)
Defective antioxidative activity of small dense HDL3 particles in type 2 diabetes:: relationship to elevated oxidative stress and hyperglycaemia
E Nobécourt et al.
DIABETOLOGIA (2005)
Genetic and environmental factors modulating serum concentrations and activities of the antioxidant enzyme paraoxonase-1
SP Deakin et al.
CLINICAL SCIENCE (2004)
Mechanisms of HDL lowering in insulin resistant, hypertriglyceridemic states: the combined effect of HDL triglyceride enrichment and elevated hepatic lipase activity
S Rashid et al.
CLINICAL BIOCHEMISTRY (2003)
High density lipoproteins and arteriosclerosis - Role of cholesterol efflux and reverse cholesterol transport
A von Eckardstein et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
Share Paper
